G-CSF Dosing to Prevent Recurrent Clozapine-Induced Agranulocytosis

Am J Psychiatry. 2016 Jun 1;173(6):643. doi: 10.1176/appi.ajp.2016.15101303.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Agranulocytosis / chemically induced*
  • Agranulocytosis / prevention & control
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Clozapine / adverse effects*
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Male
  • Psychotic Disorders / drug therapy
  • Recurrence
  • Young Adult

Substances

  • Antipsychotic Agents
  • Granulocyte Colony-Stimulating Factor
  • Clozapine